Cargando…

Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance

The activation of the Notch pathway induces glioblastoma (GBM) development. Since KDEL (Lys-Asp-Glu-Leu) containing 2 (KDELC2) is involved in the Notch pathway, the detailed mechanism is still undetermined. The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases revealed that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Yu-Ling, Chang, Hsin-Han, Chen, Ying-Chuan, Chang, Yu-Chan, Chen, Ying, Tsai, Wen-Chiuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555920/ https://www.ncbi.nlm.nih.gov/pubmed/32927743 http://dx.doi.org/10.3390/biomedicines8090339

Ejemplares similares

KDELC2 Upregulates Glioblastoma Angiogenesis via Reactive Oxygen Species Activation and Tumor-Associated Macrophage Proliferation
por: Tsai, Yu-Ling, et al.
Publicado: (2023)

PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction
por: Chang, Hsin‐Han, et al.
Publicado: (2020)

Inhibition of FABP6 Reduces Tumor Cell Invasion and Angiogenesis through the Decrease in MMP-2 and VEGF in Human Glioblastoma Cells
por: Pai, Feng-Cheng, et al.
Publicado: (2021)

ONX-0914 Induces Apoptosis and Autophagy with p53 Regulation in Human Glioblastoma Cells
por: Chang, Hsin-Han, et al.
Publicado: (2022)

Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
por: Tsai, Yu-Ting, et al.
Publicado: (2022)

AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis
por: Chen, Tzu-Chi, et al.
Publicado: (2019)

Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma
por: Chien, Chia-Hung, et al.
Publicado: (2021)

Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
por: Feng, Shao-Wei, et al.
Publicado: (2022)

Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma
por: Lo Dico, Alessia, et al.
Publicado: (2019)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
por: Singh, Neha, et al.
Publicado: (2021)

Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas
por: Chang, Yu-Chan, et al.
Publicado: (2019)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
por: Teraiya, Milan, et al.
Publicado: (2023)

Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O(6)-methylguanine-DNA methyltransferase
por: Chang, Kwang-Yu, et al.
Publicado: (2017)

SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma
por: Chien, Chia-Hung, et al.
Publicado: (2022)

Metformin treatment reduces temozolomide resistance of glioblastoma cells
por: Yang, Seung Ho, et al.
Publicado: (2016)

Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodeling
por: Tsai, Hsing-Fang, et al.
Publicado: (2021)

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
por: Gong, Lingli, et al.
Publicado: (2022)

Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
por: Chien, Chia-Hung, et al.
Publicado: (2019)

Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide
por: Feng, Shao-Wei, et al.
Publicado: (2023)

Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers
por: Lin, Chieh-Hsin, et al.
Publicado: (2022)

Glutathione S-Transferase M3 Is Associated with Glycolysis in Intrinsic Temozolomide-Resistant Glioblastoma Multiforme Cells
por: Cheng, Shu-Yu, et al.
Publicado: (2021)

Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling
por: Zhang, Xiao-Ning, et al.
Publicado: (2021)

Relation between autophagy and the resistence of glioblastoma cells to temozolomide
por: Carmo, Anália, et al.
Publicado: (2010)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
por: Martin, Sophie, et al.
Publicado: (2012)

Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
por: Almeida Lima, Karoline, et al.
Publicado: (2023)

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
por: Vengoji, Raghupathy, et al.
Publicado: (2019)

Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers
por: Lai, Chien-Rui, et al.
Publicado: (2022)

Serum-derived extracellular vesicles facilitate temozolomide resistance in glioblastoma through a HOTAIR-dependent mechanism
por: Wang, Xiaosong, et al.
Publicado: (2022)

Interplay of m(6)A and histone modifications contributes to temozolomide resistance in glioblastoma
por: Li, Fuxi, et al.
Publicado: (2021)

The Different Temozolomide Effects on Tumorigenesis Mechanisms of Pediatric Glioblastoma PBT24 and SF8628 Cell Tumor in CAM Model and on Cells In Vitro
por: Damanskienė, Eligija, et al.
Publicado: (2022)

Epigenetic Effects and Molecular Mechanisms of Tumorigenesis Induced by Cigarette Smoke: An Overview
por: Chen, Rong-Jane, et al.
Publicado: (2011)

Farnesoid X Receptor Overexpression Decreases the Migration, Invasion and Angiogenesis of Human Bladder Cancers via AMPK Activation and Cholesterol Biosynthesis Inhibition
por: Lai, Chien-Rui, et al.
Publicado: (2022)

Celecoxib reverses the glioblastoma chemo-resistance to temozolomide through mitochondrial metabolism
por: Yin, Delong, et al.
Publicado: (2021)

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
por: Yu, Jian, et al.
Publicado: (2022)

Effect of malignant‐associated pleural effusion on endothelial viability, motility and angiogenesis in lung cancer
por: Changchien, Chih‐Ying, et al.
Publicado: (2020)

XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair
por: Dai, Weimin, et al.
Publicado: (2022)

Active Component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions
por: Tung, Yu-Tang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_30k4s3ndr0g0ep21tj8mdnhcs3